Pricing Log in Create free account

Journey Medical Corporation (DERM) vs Organogenesis (ORGO)

Journey Medical Corporation and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation and Organogenesis are of similar size ($144.7M and $142.8M). Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against 6.50%. Journey Medical Corporation has the higher net margin (−8.95% vs −22.2%) and the higher return on invested capital (−5.89% vs −20.0%). Across the 19 metrics below, Organogenesis leads on 12 and Journey Medical Corporation on 7.

Valuation

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 2.00 0.28 2.11
P/B 4.26 0.86 1.78
Price to free cash flow n/m 6.11 16.14
EV/EBITDA 78.30 n/m 12.58
EV/Sales 2.00 0.21 2.73
Earnings yield (4.43%) (85.86%) (4.38%)
Free cash flow yield (16.46%) 16.36% 0.00%

Profitability

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Gross margin 65.45% 70.35% 53.94%
Operating margin (4.41%) (7.84%) 0.00%
Net margin (8.95%) (22.23%) 0.00%
Free cash flow margin (10.99%) 4.56% 0.00%
Return on equity (23.77%) (53.31%) (0.40%)
Return on assets (6.80%) (23.44%) (3.32%)
Return on invested capital (5.89%) (19.97%) 0.00%

Growth

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 20.89% 6.50% 10.01%
EPS growth (last fiscal year) 34.72% 1,600.00% 49.06%
Revenue growth, 5-year CAGR 6.79% 10.77% 6.74%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.79 0.07 0.05
Current ratio 1.59 3.52 2.31
Net debt to EBITDA (0.35) (1.14) 0.97

Dividend

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric DERM ORGO Drug Manufacturers Specialty & Generic median
Market cap 144.65m 142.83m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack